OX2 Therapeutics, Inc.
New Filing
CIK: 0001704490·Biotechnology·DELAWARE·Filed: May 17, 2017
Total Offering
$3,060,997
Amount Sold
$305,002
Investors
4
First Sale
Mar 29, 2017
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2016
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Jeff Liter | Related Person |
| Sumant Dhawan | Related Person |
| Mike Olin | Related Person |
| Christopher Moertel | Related Person |
| Thomas Martinson | Related Person |
| Ben Oehler | Related Person |
Company
SEC Filing
0001209191-17-033212
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free